Independent Scientific & Regulatory Advice
Scientific Rigor.
Strategic Insight.
Practical Solutions.
We believe better scientific decisions begin with better professional judgment.
A field of scattered points resolving into a single continuous trace — noise becoming signal.
Why Swift Strategy Group
She has sat on every side of the table.
Regulatory questions are decided by three parties: the agency that writes the rule, the company that must comply, and the board that answers for the outcome. Dr. Sibyl Swift has held a seat in all three.
Her experience shaping regulatory science, research priorities, and policy now informs client decision-making.
-
U.S. Food and Drug Administration
Associate Director for Research and Strategy, Office of Dietary Supplement Programs
Former Associate Director for Research and Strategy within FDA's Office of Dietary Supplement Programs, contributing to regulatory science, research priorities, policy development, and strategic program leadership.
Agency reasoning is not inferred from the outside. It is understood from having done the work.
Her experience carrying P&L-adjacent accountability for science, safety, quality, and regulatory outcomes now informs what clients can realistically execute.
-
cbdMD
Chief Science Officer and Vice President of Regulatory Affairs
Former Chief Science Officer and Vice President of Regulatory Affairs, with responsibility for scientific strategy, regulatory affairs, product safety, quality, clinical research, and organizational decision-making.
Recommendations are shaped by someone who has had to execute them, resource them, and answer for them.
Her experience exercising board oversight and industry-wide scientific leadership now informs how clients prepare decisions for scrutiny.
-
Natural Products Association
Senior Vice President of Scientific and Regulatory Affairs
Former Senior Vice President of Scientific and Regulatory Affairs, advising industry stakeholders on science, policy, regulatory compliance, and matters affecting dietary supplements, foods, and natural products.
-
cbdMD
Board Director
Board Director at cbdMD, contributing scientific, regulatory, governance, risk-management, and enterprise perspectives to board oversight and strategic decision-making.
-
Botanical Safety Consortium
Co-Founder
Co-Founder of a multidisciplinary scientific collaboration advancing evidence-based approaches to botanical safety and strengthening the scientific foundations of natural product evaluation.
She has not only prepared others to meet board scrutiny. She has applied it.
Swift Strategy Group
Founder and Principal
Founder and Principal of an independent advisory practice serving organizations requiring scientifically rigorous regulatory, technical, strategic, quality, and executive advice.
Advisory Focus
Integrated expertise across science, regulation, and strategy.
Dr. Sibyl Swift works with organizations whose most consequential decisions cannot be resolved through one discipline alone.
- 01
Regulatory Science & Strategy
FDA strategy, agency engagement, policy interpretation, regulatory pathways, compliance planning, and risk-based decision-making.
- 02
Scientific Evidence & Product Safety
Evidence evaluation, product safety, toxicology, clinical research, substantiation, risk assessment, and scientific communication.
- 03
Executive & Board Advisory
Independent strategic advice for executive leadership, boards, investors, legal teams, scientists, and cross-functional organizations.
- 04
Quality & Organizational Capability
Quality systems, current good manufacturing practices, documentation, corrective action, regulatory readiness, and organizational capability.
- 05
Innovation & Commercialization
Product development, regulatory strategy, botanical and biotechnology innovation, scientific claims, market readiness, and responsible commercialization.
- 06
Professional Practice & Judgment
Decision frameworks grounded in scientific integrity, independent critical thinking, disciplined professional judgment, transparency, and stewardship.
Our Professional Practice
A defined standard for how professional work is performed.
Most firms treat method as a trade secret. Here it is published in full — eight steps, seven principles, and a standard for how the work is performed.
- 01 Frame the Question Clarify the decision, define the objective, identify affected stakeholders, and establish the context in which the work will be evaluated.
- 02 Evaluate the Evidence Gather relevant information, assess reliability, distinguish fact from interpretation, and identify material gaps or uncertainty.
- 03 Exercise Judgment Integrate scientific, regulatory, legal, ethical, strategic, and practical considerations while evaluating credible alternatives.
- 04 Develop the Recommendation Form a clear, proportionate, and actionable recommendation supported by transparent reasoning and appropriate documentation.
- 05 Communicate Clearly Translate complexity into shared understanding without sacrificing accuracy, nuance, or honest acknowledgment of uncertainty.
- 06 Support Execution Help organizations translate recommendations into practical action, accountable decisions, and sustainable systems.
- 07 Review the Outcome Evaluate what worked, what changed, what remained uncertain, and what should be strengthened in future practice.
- 08 Preserve the Lesson Convert experience into institutional knowledge that improves future methodologies, decisions, and professional capability.
04 Professional Philosophy
Professional excellence is achieved through the consistent application of disciplined judgment. The quality of a recommendation depends not only upon the conclusion reached, but upon the integrity, rigor, transparency, and professional responsibility of the reasoning that produced it.
Experienced advice for complex decisions.
Begin where the Practice Cycle begins — by framing the question. Four steps, and your inquiry arrives structured for review.